Our mission is to bring pure, high quality cannabis products to medical, recreational, and international markets, while growing the industry through testing and research.
We’re multi-licensed by Health Canada for cannabis research and production, making us well-positioned to capitalize on Canada’s international lead in this growing market.
VGW is positioning to become a global, vertically integrated medical and adult-use cannabis company.
In March 2014, Valens Agritech (VAL) was founded by experienced cannabis sector participants with the goal of developing low THC cannabis oil for medical markets.
While the initial focus of Valens was cannabis-based treatment of neurological conditions for children and adults, the industry rapidly evolved. Valens evolved with it.
VAL currently holds a Dealers License and is registered as a Licensed Producer with Health Canada. We have applied for licensing to sell cannabis products to the vast recreational and international markets expected to open July 2018.
In November 2016, VAL completed a ‘going public’ RTO to become a wholly-owned subsidiary of publicly-traded Valens GroWorks (VGW), traded on the Canadian Securities Exchange (listings in the US and Germany to follow).
In March 2017 VGW acquired Supra THC services, a fully licensed testing and research lab for all manner of cannabis products.